{"success":true,"data":{"pressRelease":{"id":"172120","rtpr_id":"nWkr73mBRt-20261019","ticker":"PERPB","exchange":"Nasdaq Stockholm","all_tickers":["PERPB"],"title":"Perpetua Medical's subsidiary ES-Medical reaches agreement with its main supplier and develops next-generation cleaning system for TEE probes","author":"Cision","published_at":"2026-10-19T07:30:07.063Z","article_body":"Perpetua Medical AB\nPerpetua Medical AB (publ) (“Perpetua Medical” or the “Company”)\nannounces that its subsidiary ES-Medical has reached an agreement with Ecolab,\nenabling ES-Medical to resume production and sales of its established C10\nplatform and to develop and commercialize a next-generation cleaning system\nfor TEE probes. ES-Medical has an installed base of approximately 300 systems,\nprimarily in Scandinavia and Central Europe.\n\nOver the years, ES-Medical has developed specialist expertise in the cleaning\nand handling of transesophageal echocardiography (TEE) probes used in\ncardiology. The C10 platform was developed for automated cleaning of TEE\nprobes and has been installed in hospitals, primarily in Scandinavia and\nCentral Europe. The current installed base amounts to approximately 300\nsystems.\n\nThe agreement enables ES-Medical to resume commercialization of the C10\nplatform while continuing to develop the product platform. In parallel, the\ncompany is developing a next-generation system that builds on the experience\ngained from C10 and is designed to meet today's requirements for cleaning,\nworkflow efficiency, traceability and ease of use.\n\nThe new product is expected to be introduced to the European market during the\nfirst half of 2027, subject to obtaining the necessary regulatory approvals.\n\nAnders Hedlund, CEO of Perpetua Medical, comments:\n\n“The agreement with Ecolab and the relaunch of the C10 platform represent a\nstrategic milestone for ES-Medical in its journey towards becoming a global\nmedical technology product company. The team's specialist expertise and the\nsubstantial installed base provide an attractive business opportunity. The\ninitial launch is planned for Europe, but our long-term ambition is to become\na global leader in this niche market.”\n\nPerpetua Medical intends to provide regular updates on ES-Medical's\ndevelopment, regulatory and commercial milestones leading up to the launch.\n\nThe information was submitted for publication, through the agency of the\ncontact person set out below, on October 19, 2026 at 9.30 AM CEST.\n\n\nFor further information\n\nPlease contact:\n\nAnders Hedlund, CEO\n\nTel: +46 18 71 13 32\n\nEmail: anders.hedlund@perpetuamedical.se\n\n \n\nCertified Adviser\n\nPerpetua Medical's Certified Adviser is Mangold Fondkommission AB, which can\nbe reached by telephone at +46 8 5030 15 50 or via email at ca@mangold.se.\n\n \n\nAbout Perpetua Medical AB (publ)\n\nPerpetua Medical is an acquirer of profitable, product-oriented companies in\nthe healthcare sector. The Company believes that a decentralized ownership\nmodel, in which operations and decision-making are carried out by independent\nsubsidiaries, provides the best conditions for value creation. The company\nname Perpetua (Latin for eternal) Medical reflects the strategy of acquiring\nhealthcare companies with the intention of owning them indefinitely.\n\nThe Company's shares (ticker PERP B) are traded on Nasdaq First North\nStockholm.\n\n \n\nFurther information about the Company is available on its website:\nhttps://perpetuamedical.se/.\n\nhttps://news.cision.com/perpetua-medical-ab/r/perpetua-medical-s-subsidiary-es-medical-reaches-agreement-with-its-main-supplier-and-develops-next-%2Cc4410043\n\nRelease (https://mb.cision.com/Main/12317/4410043/4323050.pdf)\n\nPerpetua-Medical-900x700\n(https://news.cision.com/perpetua-medical-ab/i/perpetua-medical-900x700%2Cc3572957)\n\n\n\n(c) Cision 2026","article_body_html":"","raw_payload":{"data":{"id":"nWkr73mBRt-20261019","title":"Perpetua Medical's subsidiary ES-Medical reaches agreement with its main supplier and develops next-generation cleaning system for TEE probes","author":"Cision","ticker":"PERPB","created":"2026-10-19T07:30:07.063Z","tickers":["PERPB"],"exchange":"Nasdaq Stockholm","article_body":"Perpetua Medical AB\nPerpetua Medical AB (publ) (“Perpetua Medical” or the “Company”)\nannounces that its subsidiary ES-Medical has reached an agreement with Ecolab,\nenabling ES-Medical to resume production and sales of its established C10\nplatform and to develop and commercialize a next-generation cleaning system\nfor TEE probes. ES-Medical has an installed base of approximately 300 systems,\nprimarily in Scandinavia and Central Europe.\n\nOver the years, ES-Medical has developed specialist expertise in the cleaning\nand handling of transesophageal echocardiography (TEE) probes used in\ncardiology. The C10 platform was developed for automated cleaning of TEE\nprobes and has been installed in hospitals, primarily in Scandinavia and\nCentral Europe. The current installed base amounts to approximately 300\nsystems.\n\nThe agreement enables ES-Medical to resume commercialization of the C10\nplatform while continuing to develop the product platform. In parallel, the\ncompany is developing a next-generation system that builds on the experience\ngained from C10 and is designed to meet today's requirements for cleaning,\nworkflow efficiency, traceability and ease of use.\n\nThe new product is expected to be introduced to the European market during the\nfirst half of 2027, subject to obtaining the necessary regulatory approvals.\n\nAnders Hedlund, CEO of Perpetua Medical, comments:\n\n“The agreement with Ecolab and the relaunch of the C10 platform represent a\nstrategic milestone for ES-Medical in its journey towards becoming a global\nmedical technology product company. The team's specialist expertise and the\nsubstantial installed base provide an attractive business opportunity. The\ninitial launch is planned for Europe, but our long-term ambition is to become\na global leader in this niche market.”\n\nPerpetua Medical intends to provide regular updates on ES-Medical's\ndevelopment, regulatory and commercial milestones leading up to the launch.\n\nThe information was submitted for publication, through the agency of the\ncontact person set out below, on October 19, 2026 at 9.30 AM CEST.\n\n\nFor further information\n\nPlease contact:\n\nAnders Hedlund, CEO\n\nTel: +46 18 71 13 32\n\nEmail: anders.hedlund@perpetuamedical.se\n\n \n\nCertified Adviser\n\nPerpetua Medical's Certified Adviser is Mangold Fondkommission AB, which can\nbe reached by telephone at +46 8 5030 15 50 or via email at ca@mangold.se.\n\n \n\nAbout Perpetua Medical AB (publ)\n\nPerpetua Medical is an acquirer of profitable, product-oriented companies in\nthe healthcare sector. The Company believes that a decentralized ownership\nmodel, in which operations and decision-making are carried out by independent\nsubsidiaries, provides the best conditions for value creation. The company\nname Perpetua (Latin for eternal) Medical reflects the strategy of acquiring\nhealthcare companies with the intention of owning them indefinitely.\n\nThe Company's shares (ticker PERP B) are traded on Nasdaq First North\nStockholm.\n\n \n\nFurther information about the Company is available on its website:\nhttps://perpetuamedical.se/.\n\nhttps://news.cision.com/perpetua-medical-ab/r/perpetua-medical-s-subsidiary-es-medical-reaches-agreement-with-its-main-supplier-and-develops-next-%2Cc4410043\n\nRelease (https://mb.cision.com/Main/12317/4410043/4323050.pdf)\n\nPerpetua-Medical-900x700\n(https://news.cision.com/perpetua-medical-ab/i/perpetua-medical-900x700%2Cc3572957)\n\n\n\n(c) Cision 2026"},"type":"article","timestamp":"2026-10-19T07:30:07.160802207Z","server_sent_at_ms":1792395007160},"received_at":"2026-10-19T07:30:07.213Z","source_url":"https://news.cision.com/perpetua-medical-ab/r/perpetua-medical-s-subsidiary-es-medical-reaches-agreement-with-its-main-supplier-and-develops-next-%2Cc4410043"},"analysis":{"id":"160262","press_release_id":"172120","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":["next-gen launch contingent on regulatory approvals; no financial terms or revenue impact disclosed"],"eventType":"operations_update","narrative":"Perpetua Medical's subsidiary ES-Medical has reached an agreement with its main supplier Ecolab, enabling resumption of production and sales of the C10 platform for automated cleaning of TEE probes.\n\nES-Medical has an installed base of approximately 300 systems, primarily in Scandinavia and Central Europe, and is developing a next-generation cleaning system targeting European launch in the first half of 2027, subject to regulatory approvals.\n\nCEO Anders Hedlund called the agreement a strategic milestone toward becoming a global medtech product company, though the release contains no financial terms or quantified revenue impact.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Supply agreement with Ecolab reopens C10 sales and sets up a 2027 next-gen launch -- watch regulatory and commercial milestones."},"keyFigures":{"customDimensions":{"launch_window":"H1 2027 (Europe, subject to regulatory approvals)","installed_base_systems":300}},"quotedText":"The agreement with Ecolab and the relaunch of the C10 platform represent a strategic milestone for ES-Medical in its journey towards becoming a global medical technology product company.","namedEntities":{"people":[{"name":"Anders Hedlund","role":"CEO"}],"products":["C10 platform","next-generation TEE probe cleaning system"],"companies":[{"name":"Perpetua Medical AB","ticker":"PERPB","relationship":"filer/parent"},{"name":"ES-Medical","relationship":"subsidiary"},{"name":"Ecolab","relationship":"supplier"},{"name":"Mangold Fondkommission AB","relationship":"certified adviser"}],"dollarAmounts":[]},"materialImpact":{"score":3,"reasoning":"Resolution of a supply disruption with main supplier Ecolab allows the subsidiary to resume sales of the established C10 platform and enables a next-generation TEE probe cleaning system targeted for European launch in H1 2027. Material for this small-cap acquirer, but no financial figures disclosed."},"tickerRelevance":{"others":[],"primary":"PERPB"},"globalImportance":18,"audienceRelevance":8,"eventTypeSecondary":["partnership","product_launch"],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"subsidiary supplier agreement / product roadmap","householdBrandBoost":false,"retailFavoriteBoost":false}},"event_type":"operations_update","event_type_secondary":["partnership","product_launch"],"sentiment":"bullish","material_impact_score":3,"narrative":"Perpetua Medical's subsidiary ES-Medical has reached an agreement with its main supplier Ecolab, enabling resumption of production and sales of the C10 platform for automated cleaning of TEE probes.\n\nES-Medical has an installed base of approximately 300 systems, primarily in Scandinavia and Central Europe, and is developing a next-generation cleaning system targeting European launch in the first half of 2027, subject to regulatory approvals.\n\nCEO Anders Hedlund called the agreement a strategic milestone toward becoming a global medtech product company, though the release contains no financial terms or quantified revenue impact.","key_figures":{"customDimensions":{"launch_window":"H1 2027 (Europe, subject to regulatory approvals)","installed_base_systems":300}},"named_entities":{"people":[{"name":"Anders Hedlund","role":"CEO"}],"products":["C10 platform","next-generation TEE probe cleaning system"],"companies":[{"name":"Perpetua Medical AB","ticker":"PERPB","relationship":"filer/parent"},{"name":"ES-Medical","relationship":"subsidiary"},{"name":"Ecolab","relationship":"supplier"},{"name":"Mangold Fondkommission AB","relationship":"certified adviser"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-19T07:30:12.940Z","global_importance":18,"audience_relevance":8,"importance_components":{"tickerTier":"micro-cap","eventGravity":"subsidiary supplier agreement / product roadmap","householdBrandBoost":false,"retailFavoriteBoost":false}},"durationMs":5702,"modelName":"glm-5.3-flashx"}}